Historical record - last NADAC effective date: 2/21/2024
Product Information
PREGABALIN 225 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0857 per EA under NDC 69097096105. Its NADAC has been published 236 times since Aug 21, 2019.
FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
225 mg/1
Manufacturer
Cipla USA Inc.NDC
69097096105
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/21/2024
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA211384FDA Approved
7/19/2019
TE Code
AB
On Market Since
7/19/2019
Price Statistics
The NADAC for PREGABALIN 225 MG CAPSULE has been published 236 times since Aug 21, 2019, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0857 per EA |
|---|---|
| All-time high | $0.2382 (Sep 11, 2019) |
| All-time low | $0.0784 (Oct 18, 2023) |
| Median price | $0.1226 |
| Average price | $0.1291 |
| Largest weekly change | +23.9% (May 17, 2023) |
| Weeks tracked | 236 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-0.4%
5Y
-32.1%
All
-64.0%
Last surveyed Feb 21, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PREGABALIN 225 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0857 per EA (NDC 69097096105), effective Feb 21, 2024.
How has the price of PREGABALIN 225 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 64.0%. It has been tracked across 236 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?
Since Aug 21, 2019, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0784 (Oct 18, 2023) to a high of $0.2382 (Sep 11, 2019), with a median of $0.1226 per EA.
Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 225 MG CAPSULE, is $0.0562 per EA — about 34% below PREGABALIN 225 MG CAPSULE.
Who manufactures PREGABALIN 225 MG CAPSULE?
PREGABALIN 225 MG CAPSULE (NDC 69097096105) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.